The Jos University Teaching Hospital (JUTH) has partnered with pharmaceutical company Roche to provide subsidised cancer medication to patients. This announcement was made during a sensitisation programme on the engagement and pre-implementation of the NHIA-Roche Oncology Cost-Sharing Initiative held on Monday in Jos.
Speaking at the event, Pokop Bupwatda, the Chief Medical Director of JUTH, represented Njem Josiah, stated that the hospital is collaborating with the National Health Insurance Authority (NHIA) and Roche under a public-private partnership to offer affordable cancer treatment.
He explained that the partnership aims to ease the financial burden of cancer care on patients and encourage greater enrolment in the NHIA.